Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Program to prevent diabetes and dementia through lifestyle changes

Official title: Dementia and Diabetes Prevention Program (DDPP)

Run by University of California, Davis · NCT04141878 · Data updated 2026-11-12

This study is testing whether an exercise program or a healthy eating plan can help older adults at risk for cognitive decline avoid diabetes and dementia.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment400 (estimated)
SponsorUniversity of California, Davis
Academic / other
Locations1 site (Walnut Creek, California)
StatusRecruiting
StartedMay 26, 2021
Main results expectedJune 27, 2027
Study endsJune 27, 2027
Registry record updatedOctober 16, 2026
Trial IDNCT04141878 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are sedentary older adults with poor dietary habits and no significant cognitive impairment.

Probably not a fit

Patients under 60 years old or those with a BMI over 40 or significant neurological diseases will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter clinical trial evaluates two lifestyle interventions aimed at preventing diabetes and dementia in older adults at risk for cognitive decline. Participants will engage in either an aerobic exercise program or receive dietary counseling focused on the Mediterranean-DASH diet. The study will last for 8 months and includes structured sessions to promote adherence to the interventions. The trial targets older African American and non-Hispanic white individuals living in the East San Francisco Bay Area.

Why it matters

Potential benefit: If successful, this program could significantly reduce the risk of developing diabetes and dementia in at-risk populations.

How similar studies have gone: Previous studies have shown success with lifestyle interventions for diabetes and cognitive decline, indicating a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Sedentary (as per the Telephone Assessment of Physical Activity)
* Poor diet (as per the MIND Diet Screener)
* Cognitive function: absence of significant cognitive impairment as per the modified Telephone Interview for Cognitive Status (TICSm; age-, education-, and race-adjusted TICSm \>32)
* Lives in a region where the DDPP interventions will be delivered
* Does not plan to travel outside of the home geographic area for more than 3 months over the course of the study
* Free of physical disabilities that preclude participation in the study
* Willing to complete all study-related activities for 32 weeks
* Willing to be randomized to either lifestyle intervention group

Exclusion Criteria:

* Age \<60
* Body Mass Index (BMI) \>40
* Any significant neurologic disease, including any form of dementia, Parkinson's disease, Huntington's disease, normal pressure hydrocephalus, brain tumor, progressive supranuclear palsy, seizure disorder, subdural hematoma, multiple sclerosis, or history of significant head trauma with persistent neurologic sequelae or known structural brain abnormalities
* History of major depression within the last 12 months
* History of bipolar disorder or schizophrenia as per Diagnostic and Statistical Manual of Mental Disorders (DSM) V criteria
* History of alcohol or substance abuse or dependence within the past 2 years, as per DSM V criteria
* Use of psychoactive medications within the last 3 months including tricyclic antidepressants, antipsychotics, mood-stabilizing psychotropic agents (e.g., lithium salts), psychostimulants, opiate analgesics, antiparkinsonian medications, anticonvulsant medications (except gabapentin and pregabalin for non-seizure indications), systemic corticosteroids, or medications with significant central anticholinergic activity; in the absence of major depression, stable dose use of selective serotonin reuptake inhibitors or serotonin and norepinephrine reuptake inhibitors are allowed
* Health profiles that would jeopardize their safety to participate: (Screen failures will be referred immediately to a physician for medical examination): (1) Myocardial infarction or symptoms of unstable coronary artery disease (e.g., angina) in the last six months, (2) Uncontrolled hypertension within the past 6 months, (3) Morbid obesity (BMI\<40), (4) History of clinically-evident stroke, (5) Clinically-significant infection within the past 30 days, (6) Significant pain or musculoskeletal disorder limiting the ability to participate safely, or (7) Clinically significant
* Past or current use of insulin to treat type 2 diabetes
* Serious diabetic event within 6 months of enrollment
* Lung disease requiring either regular use of corticosteroids or the use of supplemental oxygen (inhaled steroids for asthma is permissible)
* Renal disease
* Clinically significant abnormalities in laboratory blood tests as per judgment of the Study Physician
* History within the last 2 years of treatment for primary or recurrent malignant disease, excluding non-melanoma skin cancers, resected cutaneous squamous cell carcinoma in situ, basal cell carcinoma, cervical carcinoma in situ, or in situ prostate cancer with normal prostate-specific antigen post-treatment
* History of hip fracture, joint replacement, or spinal surgery in the last 6 months
* Currently receiving physical therapy or cardiopulmonary rehabilitation
* History of a malabsorptive bariatric procedure (gastric bypass, biliopancreatic diversion); other bariatric procedures involving restriction (i.e., sleeve, band) are not exclusionary
* For women: currently pregnant, pregnant within the past 6 months, or planning to become pregnant within the next 6 months
* Currently incarcerated
* Receiving hospice care
* Adults unable to provide consent for participation
* PI/Study Physician discretion regarding appropriateness of participation or concern about intervention adherence

Where it's running

  • University of California, Davis Alzheimer's Disease Center
    Walnut Creek, California, United States
    Recruiting

Study contacts

  • Principal investigator: David K Johnson, PhD — University of California, Davis
  • Study coordinator: Andrea Alioto, PhD
  • Email: agalioto@ucdavis.edu
  • Phone: 925-357-6515

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Biobank for studying ALS and Alzheimer's diseases

    This study is collecting blood, skin samples, and health information from people to see how genetics might help us understand and find treatments for ALS and Alzheimer's disease.

    Recruiting New York Stem Cell Foundation Research Institute · New York, New York · NCT06203106

  • Improving decision-making for patients with dementia and diabetes

    This study is trying to help patients with dementia and diabetes, along with their caregivers, make better decisions by testing a new tool that makes it easier to understand glucose monitoring data.

    Recruiting Indiana University · Indianapolis, Indiana · NCT05643144

  • Diabetes, Dementia, and Oxidative Stress: A look at Nox2-related markers

    This study tests whether oxidative stress linked to Nox2 is related to dementia risk in adults with type 2 diabetes.

    Recruiting Neuromed IRCCS · Pozzilli · NCT07928453

  • China HEAD: a large community study on healthy aging and dementia

    This study tests whether collecting health, imaging, and biospecimen data from adults in China can help predict who will develop Alzheimer’s disease and related dementias.

    Recruiting at 30 sites Fudan University · Beijing and 29 other locations · NCT07912710

  • Doll Therapy for Apathy and Daily Living in Older Adults with Dementia

    This study tests whether doll therapy helps reduce apathy and improves starting daily activities in older adults with dementia.

    Recruiting Guangzhou Medical University · Guangdong, Guangzhou · NCT07907042

  • Aging Brain Health Initiative in Fujian

    This observational study will follow about 3,000 older adults in Fujian to see how Alzheimer's-related changes develop and to test new digital tests, biomarkers, and imaging tools for early diagnosis.

    Recruiting at 4 sites Fujian Medical University Union Hospital · Fushun, Fujian and 3 other locations · NCT07891429

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.